Urigen Pharmaceuticals announces a presentation on interstitial cystitis/painful bladder syndrome

Urigen Pharmaceuticals, Inc. (OTCBB:URGP), focused on the development of treatments for urologic disorders and pain, announces a presentation at its offices on October 30, 2009 at 2PM PST. The slides presented will be posted to its website at www.urigen.com after the close of trading that day.

“Interstitial Cystitis/Painful Bladder Syndrome is an important unmet medical need,” said Urigen CEO William J. Garner, MD. “As part of IC Awareness Week, Urigen would like to do its part to offer a presentation based on the work of its scientific founder, Lowell Parsons, MD.”